New York State Common Retirement Fund
AMRX icon

New York State Common Retirement Fund’s Amneal Pharmaceuticals AMRX Stock Holding History

New York State Common Retirement Fund’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Sell
945,445
-9,353
-1% -$128K 0.02% 556
2026
Q1 		$11.9M Buy
954,798
+113,605
+14% +$1.53M 0.02% 643
2025
Q4 		$10.6M Buy
841,193
+620,566
+281% +$7.1M 0.01% 701
2025
Q3 		$2.21M Hold
220,627
– – ﹤0.01% 1408
2025
Q2 		$1.78M Hold
220,627
– – ﹤0.01% 1447
2025
Q1 		$1.85M Hold
220,627
– – ﹤0.01% 1405
2024
Q4 		$1.75M Buy
220,627
+42,909
+24% +$360K ﹤0.01% 1463
2024
Q3 		$1.48M Sell
177,718
-21,500
-11% -$168K ﹤0.01% 1507
2024
Q2 		$1.27M Buy
199,218
+78,118
+65% +$496K ﹤0.01% 1652
2024
Q1 		$734K Sell
121,100
-903
-0.7% -$5.09K ﹤0.01% 1923
2023
Q4 		$741K Buy
122,003
+73,020
+149% +$325K ﹤0.01% 1925
2023
Q3 		$207K Buy
48,983
+497
+1% +$1.85K ﹤0.01% 2417
2023
Q2 		$150K Buy
48,486
+13,576
+39% +$28.9K ﹤0.01% 2626
2023
Q1 		$48.5K Sell
34,910
-29,955
-46% -$59.6K ﹤0.01% 2993
2022
Q4 		$129K Sell
64,865
-53
-0.1% -$119 ﹤0.01% 2890
2022
Q3 		$131K Buy
64,918
+256
+0.4% +$717 ﹤0.01% 2927
2022
Q2 		$206K Sell
64,662
-235
-0.4% -$851 ﹤0.01% 2790
2022
Q1 		$271K Buy
64,897
+60
+0.1% +$266 ﹤0.01% 2691
2021
Q4 		$311K Sell
64,837
-214
-0.3% -$1.07K ﹤0.01% 2695
2021
Q3 		$347K Sell
65,051
-32,060
-33% -$161K ﹤0.01% 2664
2021
Q2 		$497K Buy
97,111
+11,711
+14% +$66.6K ﹤0.01% 2593
2021
Q1 		$575K Hold
85,400
– – ﹤0.01% 2384
2020
Q4 		$390K Hold
85,400
– – ﹤0.01% 2468
2020
Q3 		$331K Hold
85,400
– – ﹤0.01% 2419
2020
Q2 		$407K Sell
85,400
-20,800
-20% -$85.7K ﹤0.01% 2318
2020
Q1 		$370K Hold
106,200
– – ﹤0.01% 2188
2019
Q4 		$512K Buy
106,200
+20,900
+25% +$72.7K ﹤0.01% 2292
2019
Q3 		$247K Hold
85,300
– – ﹤0.01% 2661
2019
Q2 		$612K Sell
85,300
-23,316
-21% -$238K ﹤0.01% 2264
2019
Q1 		$1.54M Buy
108,616
+23,316
+27% +$308K ﹤0.01% 1744
2018
Q4 		$1.15M Sell
85,300
-11,400
-12% -$205K ﹤0.01% 1837
2018
Q3 		$2.15M Hold
96,700
– – ﹤0.01% 1649
2018
Q2 		$1.59M Buy
+96,700
New +$1.7M ﹤0.01% 1832

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
CIP
Convergence Investment Partners Palm Beach Gardens, Florida $1.06B AUM 87.75% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

New York State Common Retirement Fund's AMRX Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Amneal Pharmaceuticals (AMRX) stake by 0.98% in Q2 2026, selling an estimated $128K and leaving 945,445 shares worth $16.4M. The position accounts for 0.02% of the portfolio, ranked #556.

New York State Common Retirement Fund first reported a position in AMRX in Q2 2018 and has held it in 33 quarters since. 81 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • New York State Common Retirement Fund held 945,445 shares of Amneal Pharmaceuticals worth $16.4M as of Q2 2026.
  • New York State Common Retirement Fund sold 9,353 Amneal Pharmaceuticals shares in Q2 2026, an estimated $128K.
  • Amneal Pharmaceuticals made up 0.02% of New York State Common Retirement Fund's portfolio in Q2 2026, its #556 holding.
  • New York State Common Retirement Fund first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
  • 81 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.